Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
6.52
-0.48 (-6.86%)
At close: Nov 20, 2026, 4:00 PM EST
6.50
-0.02 (-0.31%)
After-hours: Nov 20, 2026, 7:30 PM EST
Evolus Market Cap
Evolus has a market cap or net worth of $431.55 million as of November 20, 2026. It is the 14,743rd most valuable company in the world and the 2,757th biggest in the United States. Its market cap has decreased by 1.81% in one year.
Market Cap
431.55M
Enterprise Value
555.43M
1-Year Change
-1.81%
Global Rank
Country Rank
#2,757 United States
Category
ChartMarket Cap Chart
Since February 8, 2018, Evolus's market cap has increased from $271.30M to $431.55M, an increase of 59.07%. That is a compound annual growth rate of 5.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 431.50M | 0.09% |
| Dec 31, 2025 | 431.10M | -38.34% |
| Dec 31, 2024 | 699.10M | 16.17% |
| Dec 29, 2023 | 601.80M | 42.47% |
| Dec 30, 2022 | 422.40M | 16.75% |
| Dec 31, 2021 | 361.80M | 219.05% |
| Dec 31, 2020 | 113.40M | -66.03% |
| Dec 31, 2019 | 333.80M | 2.83% |
| Dec 31, 2018 | 324.60M | 19.65% |
| Feb 8, 2018 (IPO) | 271.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ironwood Pharmaceuticals | 778.09M |
| Collegium Pharmaceutical | 768.18M |
| Evotec SE | 489.06M |
| Alpha Teknova | 479.95M |
| Kamada | 455.78M |
| Aquestive Therapeutics | 434.88M |
| Tilray Brands | 277.19M |
| Aurora Cannabis | 274.97M |